Crypto projects are usually very good at telling you what they will become.
The roadmap is huge.
The market is enormous.
The technology will change everything.
What I find more interesting is when a project tells you what it cannot claim yet.
That sounds like a strange thing to value in Web3, but maybe it shouldn’t.
Especially in healthcare.
If a project is dealing with health data, AI, devices, and eventually medical applications, being careful with claims is not weakness.
It is probably part of the product.
And this is one reason SL Labs has become more interesting to me.
Crypto loves the future tense.
“We will onboard millions.”
“We will disrupt healthcare.”
“We will build the largest data network.”
“We will connect AI with real-world users.”
None of those statements are impossible.
The problem is that they are cheap.
Anyone can describe the future.
What is harder is separating:
what exists today
from what is being tested
from what still depends on regulation
from what is only planned
That distinction matters in every industry.
In healthcare, it matters a lot more.
There is a huge difference between building a meme app and building something related to health.
If a meme app exaggerates, users may lose interest.
If a health product exaggerates, users can misunderstand what the technology is actually capable of.
That means words matter.
“Monitoring” is not the same as diagnosis.
“Wellness” is not the same as a medical device.
“Research result” is not the same as regulatory approval.
SL Labs currently makes those boundaries fairly explicit. Its site states that SL Watch is a wellness product rather than a medical device and that it cannot determine whether disease is present. It also places medical-device functionality later in the roadmap, tied to regulatory clearance.
Honestly, I like seeing that.
Because “not yet” is sometimes much more credible than “already solved.”
Another thing I think Web3 needs more of is boring labeling.
Where did this number come from?
Is this the project’s traction?
A partner’s traction?
The parent company’s traction?
A research dataset?
A live product?
SL Labs currently points to things like 50,000 deployed CR scanners, 5,000 veterinary clinics and more than 204,000 ECG segments from joint research, while explicitly stating that parent-company traction is labeled as parent-company traction.
That last part is easy to overlook.
But it matters.
Crypto has a bad habit of taking any connection to a project and presenting it as if the project itself created all of the activity.
Partner users become “our users.”
Parent-company revenue becomes “our revenue.”
Research becomes “our product.”
Eventually nobody knows what the numbers actually mean.
Clear labels are less exciting.
They are also more useful.
This applies to AI too.
AI is moving so quickly that it is tempting to present every model as something close to intelligence.
Healthcare makes that temptation dangerous.
A useful health AI system should know where its job ends.
It can assist.
It can organize information.
It can identify patterns.
It can make workflows faster.
But the system also needs boundaries around what it should not decide.
That is not a limitation unique to SL Labs.
It is one of the fundamental challenges of building serious AI healthcare infrastructure.
The better the technology becomes, the more important those boundaries become.
SL Labs is not presenting everything as something years away.
Its current site lists live applications across several parts of the ecosystem, including HealthFi, Pet Tooth AI, THOR, Lucky Dice and Health Hero. THOR itself remains the official Ambassador Hub, built around check-ins, missions, referrals and rankings.
I think that gives users a useful way to separate two questions:
What can I interact with today?
and
What is the larger system trying to become?
Those should not be confused.
A project can have an ambitious future while still being honest about what exists now.
In fact, I trust the ambition more when the distinction is clear.
THOR looks much simpler than the healthcare side of the ecosystem.
You check in.
You complete missions.
You earn points.
You follow the project.
But maybe simplicity is exactly what the community layer needs.
Most people are not going to start by reading research papers or understanding device infrastructure.
They need somewhere easier to begin.
THOR can be that starting point.
What matters is what happens afterward.
Does someone who starts with a mission become curious about the real products?
Do they understand more of the ecosystem over time?
Do they learn which claims are live, which are research, and which are still future milestones?
That would make the ambassador layer much more valuable than a normal points campaign.
This may sound backwards in crypto, but I think projects sometimes gain credibility by saying less.
Not every feature needs to be called revolutionary.
Not every research result needs to become a medical claim.
Not every community point needs to be treated like guaranteed future money.
Not every roadmap item needs to sound inevitable.
The strongest projects eventually have enough evidence that they do not need to stretch the story.
Healthcare almost forces that discipline because the consequences of exaggeration are higher.
And maybe that discipline is exactly what Web3 needs more of.
SL Labs still has a lot to prove.
Existing infrastructure does not automatically create a successful token economy.
Research does not automatically create mass adoption.
AI does not automatically create a useful health product.
Community activity does not automatically become product retention.
Those transitions are the hard part.
But I think the right way to judge the project is to keep asking:
What is live?
What is verified?
What still depends on execution?
What still depends on regulation?
And does the project keep those categories separate?
If the answer remains clear over time, that will matter more than almost any headline.
Crypto usually rewards projects for making the biggest possible claim.
Healthcare should reward the opposite.
Precision.
Boundaries.
Evidence.
And the willingness to say:
“This works today.”
“This is still research.”
“This comes later.”
“This is not a medical claim.”
That may not create the loudest marketing campaign.
But it is probably how trust gets built.
And for a project trying to connect healthcare, AI, devices, community participation and an onchain economy, trust may end up being the most important infrastructure of all.
Explore SL Labs:
Join THOR: